MAIA Biotechnology (MAIA) Change in Receivables (2022 - 2023)
MAIA Biotechnology (MAIA) posted quarterly Change in Receivables of $16208.0 for Q4 2023, down 58.66% year-over-year from $39207.0 in Q4 2022, and up 106.1% quarter-over-quarter from -$265622.0 in Q3 2023.
MAIA Biotechnology (MAIA) Change in Receivables (2022 - 2023) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Change in Receivables for 2 consecutive years, with $16208.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Change in Receivables fell 58.66% year-over-year to $16208.0; the TTM figure through Dec 2023 stood at -$158405.0 (changed N/A YoY), while the FY2023 annual figure was -$158405.0, down 158.8% from the prior year.
- Change in Receivables climbed to $16208.0 in Q4 2023 per MAIA's latest filing, from -$265622.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $65111.0 in Q3 2022 and bottomed at -$265622.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 16,208.00 |
| Dec 31, 2023 | 16,208.00 |
| Sep 30, 2023 | -265,622.00 |
| Sep 30, 2023 | -265,622.00 |
| Jun 30, 2023 | 39,766.00 |
| Jun 30, 2023 | 39,766.00 |
| Mar 31, 2023 | 51,243.00 |
| Mar 31, 2023 | 51,243.00 |
| Dec 31, 2022 | 39,207.00 |
| Dec 31, 2022 | 39,207.00 |
| Sep 30, 2022 | 65,111.00 |
| Sep 30, 2022 | 65,111.00 |